Omega-3 properties and dosage: when it’s really worth taking capsules

A capsule labeled as 1000 mg of fish oil usually provides about 300 mg of EPA and DHA, and it is these two acids that have documented effects. This one number explains why many people supplement omega-3 for years without effect: they take three times less than they think. Another thing that marketing is silent about is the discrepancy between studies. The first large clinical trials looked spectacular, while newer, much larger ones did not confirm cardiovascular benefits at a dose of 1 g per day. In this text, we show what exactly individual studies have demonstrated, how to calculate the dose from the label, and when omega-3 interferes with medications.

KEY INFORMATION
• Omega-3 supplementation did not reduce the risk of serious vascular events in a meta-analysis of 77,917 people from 10 large studies (Aung et al., JAMA Cardiology, 2018).
• EFSA: 250-500 mg of EPA plus DHA daily for adults, and up to 5 g daily from supplements without safety concerns.
• Doses above 1 g daily are associated with a higher risk of atrial fibrillation (Gencer et al., Circulation, 2021).
• The conversion of ALA from flax to DHA is about 3.8 percent and drops by half with a diet rich in omega-6.

What are the differences between EPA, DHA, and ALA, and why can't flaxseed replace fish?

ALA from plants is a precursor, not a substitute. The body converts it to EPA in a few percent, and to DHA even less. EPA and DHA from fish and algae act directly, so they are responsible for the effects described in clinical studies.

The scale of this inefficiency is well measured. In a review of isotope studies Gerster (International Journal for Vitamin and Nutrition Research, 1998) it reports a conversion of about 6 percent to EPA and 3.8 percent to DHA, with a diet rich in omega-6 reducing it by 40-50 percent. Burdge i Calder (Reproduction Nutrition Development, 2005) they add that the conversion to EPA is limited in men, and the further conversion to DHA is very low; in women, the fraction of processed ALA is higher, probably due to estrogen.

The practical consequence concerns DHA. It is the dominant fatty acid in neuronal membranes and the retina, and its resources can only be realistically replenished through ready-made forms, from fish or microalgae. EPA behaves differently: it participates in resolving inflammation, and it is its high doses that have been studied in cardiology. Increasing flaxseed portions will not replace either of them, although it itself improves the omega-6 to omega-3 ratio in the diet.

Does omega-3 really protect the heart?

The answer is: at a dose of 1 g daily, probably not, and at 4 g of pure EPA in a narrow group of patients, probably yes. Supplement marketing is based on two studies with favorable outcomes and ignores four large trials that did not show benefits.

GISSI-Prevenzione (Lancet, 1999) included 11,324 patients after a heart attack and with 1 g of EPA plus DHA daily reduced the risk of death by 20 percent, and cardiovascular death by 30 percent in a four-arm analysis. This study was conducted in the 1990s, before the era of widespread statin therapy. REDUCE-IT (Bhatt i in., New England Journal of Medicine, 2019) administered 4 g of EPA ethyl ester to patients on statins and with elevated triglycerides: the primary endpoint occurred in 17.2 percent of those treated compared to 22.0 percent on placebo.

Newer trials have yielded different results. In the VITAL study (25,871 participants, 1 g daily), the risk ratio for serious cardiovascular events was 0.92 and was not significant. ASCEND in 15,480 people with diabetes yielded a result of 0.97. STRENGTH with 4 g daily on 13,078 patients was prematurely stopped due to lack of chance to demonstrate benefits. A meta-analysis Aung i in. (JAMA Cardiology, 2018) gathered 77,917 people from 10 studies and found no association between supplementation and serious vascular events (RR 0.97). It is worth noting that the placebo in REDUCE-IT was mineral oil, and in STRENGTH corn oil, and some cardiologists attribute the difference in results to this choice of comparator.

How much omega-3 should you take daily and how to calculate the dose from the label?

For adults, EFSA recommends 250-500 mg of EPA plus DHA daily, which corresponds to roughly two servings of fatty fish per week. Higher doses only make sense with specific indications and under medical supervision, as this is already a pharmacological level, not a nutritional one.

The biggest trap is the arithmetic of the label. The manufacturer provides the weight of fish oil, but what counts is the sum of EPA and DHA. A typical 1000 mg capsule contains 180 mg of EPA and 120 mg of DHA, which means 300 mg of what works. Concentrates with 60-90 percent content allow you to fit the same dose in one capsule instead of four. We have noticed in conversations with customers that after recalculating servings to EPA plus DHA, most people discover that for years they have been taking a fraction of the dose they read about in articles.

In cases of very high triglycerides, a dose of 4 g daily lowers them by at least 30 percent according to stanowiska American Heart Association (Circulation, 2019). To leczenie zaburzenia lipidowego, a nie profilaktyka dla osoby zdrowej.

When can omega-3 be harmful and which medications should be approached with caution?

Omega-3 is not neutral above nutritional doses. Two signals are well documented: an increased risk of atrial fibrillation at high doses and an effect on coagulation, which is significant for people taking anticoagulant and antiplatelet medications.

Meta-analysis Gencer i in. (Circulation, 2021) included 81,210 patients from 7 studies and showed an increased risk of atrial fibrillation with marine omega-3 supplementation (HR 1.25). The relationship increases with the dose: for trials with a dose above 1 g daily, HR was 1.49, and for doses up to 1 g, it was 1.12. The REDUCE-IT trial recorded hospitalizations due to atrial fibrillation or flutter in 3.1 percent of treated patients compared to 2.1 percent on placebo.

The issue of bleeding requires separating two things. EFSA in its 2012 opinion stated that supplements providing up to 5 g of EPA plus DHA daily do not increase the risk of spontaneous bleeding in healthy individuals. It is different with medications: omega-3 inhibits platelet aggregation, and in REDUCE-IT, serious bleeding occurred in 2.7 percent of treated patients compared to 2.1 percent on placebo. If you are taking warfarin, acenocoumarol, acetylsalicylic acid, or clopidogrel, do not start supplementation without consulting your doctor, and before a planned procedure, determine the timing for stopping the supplement. The same applies to individuals with a history of atrial fibrillation.

Which omega-3 effects are well proven, and which are weak?

The evidence is unevenly distributed. The strongest relates to lowering triglycerides and pregnancy, while the weakest pertains to dementia prevention and dry eye. The following summary organizes what emerges from large studies and systematic reviews, not from manufacturer materials.

In pregnancy, the data is the strongest in the entire summary. Review Cochrane (Middleton i in., 2018) It gathered 70 studies involving 19,927 women and showed a reduction in births before 34 weeks from 4.6% to 2.7%.

How do omega-3s affect the brain, mood, and memory?

DHA builds neuronal membranes, so its deficiency has developmental significance, but supplementation in healthy individuals does not protect against dementia. The situation is more interesting with depression: the supportive effect is attributed to EPA, not DHA, and only as an adjunct to treatment.

Meta-analysis Martins (Journal of the American College of Nutrition, 2009) It included 28 randomized trials and showed that effectiveness depends on the ratio: preparations with a predominance of EPA were helpful, while those dominated by DHA were not. The likely mechanism operates through inflammatory pathways, as depression has a documented inflammatory component. This is not a standalone therapy and does not replace psychiatric treatment.

With memory, the results depend on the starting point. Yurko-Mauro i in. (Alzheimer’s and Dementia, 2010) They administered 900 mg of DHA daily for 24 weeks to 485 individuals over 55 years old with age-related memory decline and noted improvements in associative learning tests and word recognition. In the AREDS2 study (Chew et al., JAMA, 2015), where 1 g of omega-3 was given for 5 years to individuals without deficits, no cognitive benefits were observed. Thus, supplementation appears to be filling a deficiency rather than enhancing a healthy brain.

Does omega-3 reduce inflammation and accelerate recovery?

The mechanism is real, but clinical effects are often more modest than expected. EPA and DHA are substrates for resolvins and protectins, which are mediators of inflammation resolution. This action is different from anti-inflammatory drugs that block the formation of prostaglandins.

Calder (British Journal of Clinical Pharmacology, 2013) It draws attention to the dose threshold: in adults, the anti-inflammatory effect usually requires over 2 g of EPA plus DHA daily, and there are few studies establishing the dose. In rheumatoid arthritis, the balance is favorable. A review Akbar i in. (Journal of Clinical Rheumatology, 2017) summarized 20 clinical trials, of which 16 showed improvement in disease parameters.

In inflammatory bowel diseases, the picture is the opposite of what is often repeated. The Cochrane review regarding Crohn's disease (Lev-Tzion et al., 2014) deemed omega-3 probably ineffective in maintaining remission and noted more frequent diarrhea and upper gastrointestinal complaints. An earlier review regarding ulcerative colitis found no data supporting its use. In post-exercise recovery, the data is preliminary: Smith i in. (Clinical Science, 2011) they administered 4 g daily for 8 weeks to nine healthy individuals aged 25-45 and observed a stronger anabolic response of muscles to insulin and amino acids. This is nine participants, so treat this result as a hypothesis.

Fish, algae, or hemp seeds: which source and which supplement to choose?

If you eat fatty fish twice a week, you provide yourself with as much EPA and DHA as recommended by EFSA, and supplementation adds nothing. Supplementation makes sense with a fish-free diet, during pregnancy, and with a doctor's recommendation. Vegans have one good option: oil from microalgae.

Geppert i in. (Lipids, 2005) They administered 0.94 g of DHA from microalgae daily for 8 weeks to 104 vegetarians and raised the omega-3 index from 4.8% to 8.4%, while the level of EPA increased much more weakly. This is important practical information: an algal preparation based solely on DHA supplements one of the two acids, so for indications dependent on EPA, look for a version containing both.

Hemp seeds and hemp seed oil provide ALA in an omega-6 to omega-3 ratio close to 3:1, which Gerster indicates as favorable for conversion. This is a sensible element of a daily diet and a real improvement in fatty acid ratios, but not a source of EPA or DHA. When choosing capsules, look at the sum of EPA plus DHA per serving, the purity certification such as IFOS or NSF, and freshness, as oxidized oil loses its effectiveness and causes a characteristic fishy aftertaste. After opening, store the package in a cool place. From our experience, it is this aftertaste, rather than a lack of effect, that most often ends supplementation after a few weeks.

Frequently Asked Questions

How much omega-3 to take daily?

EFSA recommends 250-500 mg of EPA plus DHA daily for adult Europeans. Therapeutic doses of 2-4 g for high triglycerides are up to the doctor. Count the sum of EPA plus DHA from the label, not the mass of fish oil: a 1000 mg capsule usually contains about 300 mg of what works.

Does ALA from flax and chia replace EPA and DHA from fish?

No. The conversion reaches about 6% to EPA and 3.8% to DHA, and a diet rich in omega-6 reduces it by 40-50% (Gerster, 1998). Flaxseed, chia, and hemp seeds are valuable, but do not provide ready-made EPA or DHA.

Czy omega-3 wchodzi w interakcje z lekami przeciwzakrzepowymi?

Yes, and this is the most important warning in this text. Omega-3 inhibits platelet aggregation, so if you are on warfarin, acenocoumarol, or clopidogrel, inform your doctor. In REDUCE-IT, serious bleeding occurred in 2.7% of treated individuals compared to 2.1% on placebo. Before any procedure, establish a discontinuation date.

When is the best time to take omega-3?

With a meal containing fat. Lawson i Hughes (BBRC, 1988) They demonstrated an increase in EPA absorption from triglycerides from 69% to 90%, and from ethyl esters about threefold. The time of day has no documented significance; regularity and the presence of fat in the meal matter.

Does omega-3 from fish contain mercury?

Mercury accumulates in the muscles of fish, not in the fat, so fish oil contains much less than the flesh of predatory fish. IFOS and NSF certifications confirm heavy metal content below standards. Raw material from sardines or anchovies is safer in this regard than from tuna.

Does omega-3 help with dry eyes?

Badanie DREAM (New England Journal of Medicine, 2018) administered 3000 mg of EPA plus DHA for 12 months and did not show an advantage over placebo with olive oil. Earlier, smaller trials were more favorable, so the evidence remains conflicting, and omega-3 does not replace ophthalmic treatment.

If you are looking for a product with a measurable content of EPA and DHA, start with the label, not the slogan on the package. You can find the current assortment in the category supplements, and we discuss plant-based nutritional gaps more broadly in the post suplementy dla wegetarian i wegan.

The article is informational and educational in nature and does not constitute medical advice. Before starting to use omega-3 supplements for therapeutic purposes, consult your doctor, especially if you are taking other medications, are pregnant, or breastfeeding.

Author: Michał Waluk · Opublikowano: 2026-06-22 · Aktualizacja: 2026-08-07